A cure for Type 1 diabetes may be possible through the use of stem cells.

The global population with diabetes is increasing.

Insulin is necessary for Type 1 diabetics because their immune system attacks and destroys the beta cells in the pancreas that produce it. These cells regulate glucose levels in the blood, which the body needs for energy. Without insulin, blood sugar will continue to rise, requiring lifelong injections.

Over the past 20 years, stem cell research and therapies have shown promising methods for creating new insulin-producing cells, which are essential for treating Type 1 diabetes.

A biotech company has commenced a clinical trial to treat 17 individuals with Type 1 diabetes using new insulin-producing cells derived from stem cells. The first participant, Brian Shelton, has experienced positive outcomes. Following 150 days, Shelton was able to decrease the amount of insulin he administers by 92%.

In addition to Pfizer, other global companies are also working to cure diabetes, including ViaCyte and Novo Nordisk, one of the largest insulin manufacturers globally.

Listen to the video to learn about how stem cell therapy has improved Shelton's life and the other potential cures for diabetes being researched.